Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.
2.

[QT interval prolongation and psychotropic drugs in children and adolescents: proposed guideline].

van Aerde KJ, Kalverdijk LJ, Reimer AG, Widdershoven JA.

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1765-70. Review. Dutch.

PMID:
18754307
3.

Modern cardiovascular standards for psychotropic drugs.

Roose SP.

Psychopharmacol Bull. 1992;28(1):35-43. Review.

PMID:
1609041
4.

Cardiovascular effects of psychotropic drugs.

Feinstein RE, Khawaja IS, Nurenberg JR, Frishman WH.

Curr Probl Cardiol. 2002 May;27(5):190-240. Review. No abstract available.

PMID:
12060825
5.

Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.

Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL; American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young..

Circulation. 2007 Jun 12;115(23):3015-38. Epub 2007 May 22. Review.

6.

Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.

Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism..

Circulation. 2009 Feb 3;119(4):628-47. doi: 10.1161/CIRCULATIONAHA.108.191394. Epub 2009 Jan 12. No abstract available.

8.

The QT interval and psychotropic medications in children: recommendations for clinicians.

McNally P, McNicholas F, Oslizlok P.

Eur Child Adolesc Psychiatry. 2007 Feb;16(1):33-47. Epub 2006 Aug 29. Review.

PMID:
16944043
9.

Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee.

Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M.

Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1689-92. Review. No abstract available.

10.

Effects of psychotropic drugs on the cardiovascular system.

Baello EB Jr, Skorton DJ.

J Iowa Med Soc. 1983 Sep;73(9):370-2. Review. No abstract available.

PMID:
6355324
11.

Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.

Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL; American Heart Association Council on Cardiovascular Disease in the Young..

Circulation. 2007 Jun 12;115(23):2995-3014. Epub 2007 May 22. Review.

12.

Psychotropic drugs--neurotoxicity.

Zaratzian VL.

Clin Toxicol. 1980 Sep;17(2):231-70. Review. No abstract available.

PMID:
6998646
13.

Psychotropic drugs, cardiac arrhythmia, and sudden death.

Witchel HJ, Hancox JC, Nutt DJ.

J Clin Psychopharmacol. 2003 Feb;23(1):58-77. Review.

PMID:
12544377
14.
15.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
16.

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.

Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, Bailey JJ, Childers R, Gorgels A, Josephson M, Kors JA, Macfarlane P, Mason JW, Pahlm O, Rautaharju PM, Surawicz B, van Herpen G, Wagner GS, Wellens H; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology.; American College of Cardiology Foundation.; Heart Rhythm Society..

J Am Coll Cardiol. 2009 Mar 17;53(11):992-1002. doi: 10.1016/j.jacc.2008.12.015. Review. No abstract available.

17.

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.

Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, Bailey JJ, Childers R, Gorgels A, Josephson M, Kors JA, Macfarlane P, Mason JW, Pahlm O, Rautaharju PM, Surawicz B, van Herpen G, Wagner GS, Wellens H; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology.; American College of Cardiology Foundation.; Heart Rhythm Society..

Circulation. 2009 Mar 17;119(10):e251-61. doi: 10.1161/CIRCULATIONAHA.108.191097. Epub 2009 Feb 19. Review. No abstract available.

18.

Practitioner review: Psychopharmacology in children and adolescents with mental retardation.

Handen BL, Gilchrist R.

J Child Psychol Psychiatry. 2006 Sep;47(9):871-82. Review.

PMID:
16930381
19.

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT; American Heart Association..

J Am Dent Assoc. 2008 Jan;139 Suppl:3S-24S. Review. Erratum in: J Am Dent Assoc. 2008 Mar;139(3):253.

PMID:
18167394
20.

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.

Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, Hancock EW, Josephson M, Kligfield P, Kors JA, Macfarlane P, Mason JW, Mirvis DM, Okin P, Pahlm O, Rautaharju PM, van Herpen G, Wagner GS, Wellens H; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology.; American College of Cardiology Foundation.; Heart Rhythm Society..

J Am Coll Cardiol. 2009 Mar 17;53(11):976-81. doi: 10.1016/j.jacc.2008.12.013. Review. No abstract available.

Supplemental Content

Support Center